Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Comments on Initial Guidance for the Medicare Drug Price Negotiation Program, IPAY 2028
HOME
/
Policy Interactions
/
Comments on Initial Guidance for the Medicare Drug Price Negotiation Program, IPAY 2028